Bioactive Materials Market Expected To Trigger A Revenue Increase To USD 3.29 Billion By 2025:Key Participant Zimmer Holding Inc., Medtronic Inc.

San Francisco, 24 December 2018, Bioactive Materials Market Analysis By Type (Powder, Moldable, Granules), By Material (Glass, Glass-Ceramic, Composite), By Application, By Region, And Segment Forecasts, 2018 – 2025

The global bioactive materials market is expected to reach USD 3.29 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness a CAGR of 10.1% over the forecast period, owing to rising substitution of engineered plastics in implants.

Increasing healthcare expenditure by the consumers is expected to drive the demand for bioactive materials over the forecast period. Rising geriatric population is likely to trigger the demand for such products primarily for use in the production of prosthesis and implants, thereby driving the market over the next eight years.

Growing use of bioactive materials for coating metal implants to promote bone healing & osteogenesis, and mitogenesis of undifferentiated cells is expected to drive the market growth over the forecast period. The demand for such products is likely to rise on account of growing product adoption by consumers including hospitals and private surgeons.

The industry is expected to benefit from the rising technological advancements across the globe. In addition, the products are expected to gain traction over the forecast period driven by the superior performance in bone regeneration surgeries.

Access Full Research Report On Bioactive Materials Market Analysis:

www.grandviewresearch.com/industry-analysis/bioactive-materials-industry

Further key findings from the report suggest:

·         Glass accounted for a market share of 37.7% in 2016, of the material segment, growing at a CAGR of 12.4% from 2017 to 2025, owing to its successful clinical applications and rising use in tissue engineering

·         Powder accounted for 23.4% of the overall revenue share in 2016, due to high demand in tooth implants and other dentistry applications driven by superior amalgamation properties

·         The market for bioactive materials in surgery is expected to grow at CAGR of 11.3% from 2017 to 2025. Recent advancements in the stem cell technology have boosted the demand for bioactive materials in the field of medicine and science and the trend is expected to sustain over the forecast period

·         North America accounted for the highest global share of 37.0% in 2016 driven by high per capita healthcare spending owing to Affordable Care Act (ACA) introduced by the Obama administration in 2010

·         Key participants of the industry include Zimmer Holding Inc., Medtronic Inc., Stryker Corporation, and Depuysynthes, with the companies focusing on new technology, excellent performance and customized products to gain market share

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/advanced-materials

Grand View Research has segmented the bioactive materials market on the basis of material, type, application and region:

Bioactive Materials, Materials Outlook (Revenue, USD Million, 2014 - 2025)

·         Glass

·         Glass Ceramic

·         Composite

·         Others

Bioactive Materials, Type Outlook (Revenue, USD Million, 2014 - 2025)

·         Powders

·         Moldables & Injectables

·         Granules

·         Others

Bioactive Materials, Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Dentistry

·         Surgery

·         Bioengineering

·         Others

Bioactive Materials, Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    China

o    India

o    Japan

·         Central & South America

·         Middle East & Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-bioactive-materials-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Nerve Repair And Regeneration Market Expected To Trigger A Revenue Increase To 15.7 Billion By 2024:Key Participant Boston Scientific, Inc., Stryker Corporation

San Francisco, 21 November 2018, The global nerve repair and regeneration market is expected to reach USD 15.7 billion by 2024, according to a new report by Grand View Research Inc. The demand for neurological disorder devices and therapies is expected to upsurge over the forecast period owing to rising awareness, increasing incidence rate, government funding & reimbursement policies, and uninterrupted technological advances by the key players of the industry (nerve control and regeneration technique is a rapidly growing division of neural tissue engineering). It has been estimated that more than 0.8 million people were affected due to nervous system injuries per year.

In January 2016, The EU Horizon 2020 program funded a research project ‘Autostem’ launched by the NUI Galway’s Regenerative Medicine Institute (REMEDI) costing about USD 6.73 million. This project was expected to develop a robotic stem cell production factory, having an edge over the old traditional techniques. Also, this technique will treat a range of therapies pertaining to cancer, diabetes, arthritis and other diseases.

Investment by market players in research & development and commercialization in emerging countries are the major factors to drive the market growth in coming years. For instance, in October 2015, Helius Medical signed an agreement with A&B Company Limited for the development and commercialization of Helius’ Portable Neuromodulation Stimulator in Singapore, Taiwan, Hong Kong, Macao, and China. Under this agreement, A&B is expected to acquire certain Asian patents ownership, product support material, and patent applications for the PoNS device.

Access Full Research Report On Nerve Repair And Regeneration Market Analysis:
www.grandviewresearch.com/industry-analysis/nerve-repair-regeneration-market

Further Key Findings From the Study Suggest:

·         Neurostimulation and neuromodulation devices dominated the product segment of the market in 2015 due to the rising awareness about the devices, coupled with the increasing central nervous system disorders in the population.

·         Biomaterials segment is anticipated to grow at the fastest rate during the forecast period. This can be attributed to technological advancement, development of biodegradable polymers which are expected to enhance spinal stabilization, healing of fractures, & reduce hospitalization, and rising adoption.

·         North America dominated the market in 2015 owing to the technological advancements in the region and the introduction of new devices by the manufacturers. In 2015, U.S proved to be the most potential market. Increasing injuries to the central nervous system (CNS), including injuries to the spinal cord and the brain, increased cases, initiatives and funding from governments and various other agencies were some of the major reasons of growth.

·         According to the report published by the Florida university, more than 2 million people were suffering with traumatic injuries of the brain in the US annually and 5,00,000 people suffered due to the spinal cord injuries. The major causes of CNS injuries result from poorly understood biochemical pathological events.

·         Also, In March 2016, Baxter completed the CE marking, the indication for marketing of ‘HEMOPATCH’ the ready-to-use surgical patch in the European market. This patch was approved for use during traumatic injuries of the brain, CNS or other body parts that result in shrinkage of dura mater also, as a hemostatic device to prevent loss of blood or any other body fluid.

·         Asia Pacific is expected to be the fastest growing region during the forecast period. An aging population, technological advancement and presence of unmet medical needs are some of the reasons for the growth of the market.

·         In February 2016, Indian scientists working for Revita Life Sciences were approved to conduct clinical trials in 20 clinically dead patients to bring specific parts of their central nervous system back to life. Combination of therapies including cocktail of peptides, nerve stimulation techniques, injecting the brain with stem cells and other techniques that were successful in bringing patients out of coma were to be used. Existing medical devices were combined with regenerative biological medicines with an objective to achieve such a complex initiative.

·         Manufacturers are conducting collaborative exercises by use of innovative devices and therapies to improve the efficiency of treatment and provide better results.

·         Some key players in this industry include Boston Scientific, Inc., Stryker Corporation, St. Jude Medical, Inc., Medtronic plc., Baxter International, Inc., AxoGen, Inc., Polyganics B.V., Integra Lifesciences Corporation, and Cyberonics, Inc.

Browse More Reports Of This Category By Grand View Research At:  www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the nerve repair and regeneration market by product, surgery, and region:

Nerve Repair and Regeneration Product Mode Outlook (Market revenue in USD Million, 2013 - 2024)

·         Biomaterial

·         Neurostimulation and neuromodulation devices

o    Spinal cord stimulation devices

o    Deep brain stimulation devices

o    Sacral nerve stimulation devices

o    Vagus nerve stimulation devices

o    Gastric electric stimulation devices

Nerve Repair and Regeneration Surgery Outlook (Revenue, USD Million, 2013 - 2024)

·         Direct nerve repair/neurorrhaphy

·         Nerve grafting

·         Stem cell therapy

·         Neurostimulation and neuromodulation surgeries

Nerve Repair and Regeneration Regional Outlook (Market Revenue in USD Million, 2013 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o    UK

o    Germany

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

·         Middle East and Africa

o    South Africa

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/bric-breast-pump-market-analysis

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com/

Surgical Drainage Devices Market Worth USD 2.3 Billion By 2025 | Key Industry Players Acelity, Teleflex Incorporated

San Francisco, 26 September 2018 ,The global surgical Drainage Devices market is anticipated to reach USD 2.3 billion by 2025, according to a new report by Grand View Research, Inc. The growth of this market is catapulted by increasing incidence of chronic diseases, the need to curb healthcare expenditure, and additional benefits associated with surgical drain devices. Majority of the times, these devices are used for prevention of fluid accumulation and in postsurgical treatment & care. 

With the escalating number of diseases that require surgical intervention, these devices are now being used in hospitals, clinics, and ambulatory surgical centers. Active surgical drain devices make use of negative pressure or vacuum to remove fluid buildup, and are preferred over conventional passive drain devices as they help in healing the wound quickly.

Drainage devices are used in cardiothoracic surgeries, neurosurgical procedures, orthopedic surgeries, and abdominal surgeries among others. Global rise in musculoskeletal diseases, arthritis, and osteoporosis has resulted in an increase in number of surgeries being performed, which has further led to an increase in adoption of these devices.

The North American region accounted for the largest market share due to technologically advanced medical infrastructure and successful integration of ambulatory health services in its healthcare system. Emerging countries like India, China, and Brazil are also expected to flourish during the forecast period owing to their developing healthcare infrastructure and increasing adoption of advanced medical technology to curb chronic diseases.

Full Research Report On Surgical Drainage Devices Market Analysis:
www.grandviewresearch.com/industry-analysis/surgical-drainage-devices-market

Further Key Findings From The Study Suggest:

·         Active surgical devices are expected to gain considerable market share owing to their increasing usage in surgeries

·         With a wide range of passive surgical drain devices being available in the market, product penetration is high, fetching them adequate share in the market

·         With an increase in the incidence of musculoskeletal diseases, arthritis, and osteoporosis, orthopedics application is expected to witness the fastest growth during the forecast period

·         Cardiothoracic application is expected to be the largest segment due to global rise in cardiovascular diseases and the number of surgeries being performed

·         North America accounted for the largest market share owing to local presence of dominant players in the market and availability of sophisticated infrastructure as well as existence of healthcare reforms to curb the incidence of chronic diseases

·         The Asia Pacific region is expected to flourish during the forecast period owing to the change in various healthcare reforms and development of new medically advanced technologies

Browse More Reports Of This Category By Grand View Research At:
www.grandviewresearch.com/industry/medical-devices

Grand View Research has segmented the global surgical drainage devices on the basis of product, application, end-use, and region:

Surgical Drainage Devices Product Outlook (Revenue, USD Million; 2014 - 2025)

·         Active Drainage Devices

·         Passive Drainage Devices

Surgical Drainage Devices Application Outlook (Revenue, USD Million; 2014 - 2025)

·         Cardiothoracic

·         Neurosurgery

·         Abdominal Surgery

·         Orthopedics

·         Others

Surgical Drainage Devices End-use Outlook (Revenue, USD Million; 2014 - 2025)

·         Hospitals

·         Clinics

·         Ambulatory Surgical Centers

Surgical Drainage Devices Regional Outlook (Revenue, USD Million; 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

o    France

o    Italy

o    Spain

·         Asia Pacific

o    Japan

o    China

o    India

·         Latin America

o    Brazil

o    Mexico

·         MEA

o    South Africa

o    Saudi Arabia

Access Full Press Release of this Report:
www.grandviewresearch.com/press-release/global-surgical-drainage-devices-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For more information: www.grandviewresearch.com